CAR T-Cell Study in NHL Patients Shows Activity and Feasibility – Clinical Oncology News
Clinical Oncology News |
CAR T-Cell Study in NHL Patients Shows Activity and Feasibility
Clinical Oncology News San Diego—Once again, a study has found that chimeric antigen receptor (CAR) T cells have impressive activity in highly treatment-experienced patients with a refractory hematologic malignancy. In this Phase II trial, the focus was non-Hodgkin lymphoma … |
